Champoux Jennifer
Monte Rosa Therapeutics, Inc. · Chief Operating Officer
Champoux Jennifer is listed in filings as Chief Operating Officer at Monte Rosa Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including sale activity. Recent filings connect the profile to Monte Rosa Therapeutics, Inc. (GLUE). The current snapshot covers public activity from Jan 6, 2025 to May 28, 2026. Reported amounts are shown as $43.5K to $41.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $41k2.2k shares | SellMay 22, 2026 | $19.00 | $23.79 | |
| $40k2.6k shares | SellJan 5, 2026 | $15.17 | $23.79 |